Azacitidine,Magrolimab,Venetoclax
Gilead,Roche,Abbvie
['leukemia', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'myeloid', 'magrolimab', 'venetoclax', 'leusm']
magrolimab in combination with azacitidine and venetoclax was well tolerated and yielded promising responses among patients with high-risk acute myeloid leukemia regardless of tp53 mutation status. #leusm #ash22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.